Related references
Note: Only part of the references are listed.SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial
Barbara H. McGovern et al.
CLINICAL INFECTIOUS DISEASES (2021)
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
Mark R. Charbonneau et al.
COMMUNICATIONS BIOLOGY (2021)
Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics
Xiao Tan et al.
CELL (2021)
Short and long-read ultra-deep sequencing profiles emerging heterogeneity across five platform Escherichia coli strains
Peter Rugbjerg et al.
METABOLIC ENGINEERING (2021)
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip
M. Tyler Nelson et al.
NATURE COMMUNICATIONS (2021)
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study
Marja K. Puurunen et al.
NATURE METABOLISM (2021)
Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents
Jens Walter et al.
CELL (2020)
P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD)
W Reinisch et al.
Journal of Crohns & Colitis (2020)
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Candice R. Gurbatri et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Mark R. Charbonneau et al.
NATURE COMMUNICATIONS (2020)
Controlling the Growth of the Skin Commensal Staphylococcus epidermidis Using D-Alanine Auxotrophy
David Dodds et al.
MSPHERE (2020)
The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review
Angharad Steele et al.
ANTIBIOTICS-BASEL (2020)
Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox
Danielle B. Pedrolli et al.
TRENDS IN BIOTECHNOLOGY (2019)
An exclusive metabolic niche enables strain engraftment in the gut microbiota
Elizabeth Stanley Shepherd et al.
NATURE (2018)
Next-generation biocontainment systems for engineered organisms
Jeong Wook Lee et al.
NATURE CHEMICAL BIOLOGY (2018)
Current understanding of the human microbiome
Jack A. Gilbert et al.
NATURE MEDICINE (2018)
Probiotic strains detect and suppress cholera in mice
Ning Mao et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications
Josef R. Bober et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 20 (2018)
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Vincent M. Isabella et al.
NATURE BIOTECHNOLOGY (2018)
Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
David T. Riglar et al.
NATURE BIOTECHNOLOGY (2017)
Repurposing a Two-Component System-Based Biosensor for the Killing of Vibrio cholerae
Premkumar Jayaraman et al.
ACS SYNTHETIC BIOLOGY (2017)
Mining the Human Gut Microbiota for Immunomodulatory Organisms
Naama Geva-Zatorsky et al.
CELL (2017)
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
Clement T. Y. Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
Recoded organisms engineered to depend on synthetic amino acids
Alexis J. Rovner et al.
NATURE (2015)
Detection of antibiotic resistance in probiotics of dietary supplements
Aloysius Wong et al.
NUTRITION JOURNAL (2015)
Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates
Alexis Courbet et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Synthetic Microbes As Drug Delivery Systems
Jan Claesen et al.
ACS SYNTHETIC BIOLOGY (2015)
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
Jerry Vockley et al.
GENETICS IN MEDICINE (2014)
Principles of genetic circuit design
Jennifer A. N. Brophy et al.
NATURE METHODS (2014)
Phase 1b, Multicenter, Single Blinded, Placebo-Controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects With Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy
Sewanti Atul Limaye et al.
CANCER (2013)
Bacterial colonization factors control specificity and stability of the gut microbiota
S. Melanie Lee et al.
NATURE (2013)
Synthetic circuits integrating logic and memory in living cells
Piro Siuti et al.
NATURE BIOTECHNOLOGY (2013)
Preparing synthetic biology for the world
Gerdh. G. Moe-Behrens et al.
FRONTIERS IN MICROBIOLOGY (2013)
Chemical Evolution of a Bacterium's Genome
Philippe Marliere et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
L Steidler et al.
NATURE BIOTECHNOLOGY (2003)
Share Paper
